Stocks and Investing
Stocks and Investing
Tue, July 18, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, July 17, 2017
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Amsellem Downgraded (SUPN) to Hold on, Jul 17th, 2017
David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold on, Jul 17th, 2017.
David has made no other calls on SUPN in the last 4 months.
There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ken Trbovich of "Janney Montgomery Scott" Initiated at Hold and Held Target at $47 on, Friday, July 14th, 2017